-
I think this is one that should have support and would pass as it has been passed before but the scientists want it done before other issues begin to cloud the water as there’s no Bush veto waiting around this time. If the judge has determined a law is needed, then make one here as the rest of...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Nov 7 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Genomics, Science, Congress, NIH, Research and Development, Stem Cells, Laws
-
This is pretty much a no brainer in concept as many of the new devices and what is being approved revolves around software, thus they might think about understanding the basic concepts of what software (algorithms) does. Actually this could be a good move as more would perhaps jump into the consumer...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Oct 13 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Medical Devices, FDA, Congress, software, Transparency, Non participants, algoirthms, Algo man
-
Back in 2009, Johnson and Johnson bought Cougar Biotech here in Los Angeles, who has not yet brought a product to market, but it appears from the results with the latest reports on their prostate cancer drug, it might soon be in the works for submission to the FDA. Johnson and Johnson Acquiring...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Oct 11 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Biotech, FDA, Congress, Prostate Cancer, Johnson and Johnson, drug manufacturers, pipeline, Cougar Biotech
-
This is truly a good thing as I have interviewed companies such as Cook Medical for one in the past and this is one item they is always a bear for them, the FDA stamp of approval is one thing, but coverage, which is what makes the product available is the other big mountain to climb. I think this decision...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Sep 17 2010
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Medical Devices, FDA, Congress, HHS, cell phones, CMS, wireless, Telehealth, FCC, participatory Sensing, devices that report data, tech denial, infrastructure, barcodes
-
This is one “huge” project and the targets and technologies change frequently, maybe hourly if we really had all the data to look at. Technology is out there throwing us a new left curve every day and when it available and simple, consumers want it now. No longer are we in the days to where...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Sep 15 2010
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, My Commentaries, tags, Medical Devices, Health IT, FDA, Congress, HHS, cell phones, wireless, Telehealth, UCLA, role models, FCC, participatory Sensing, devices that report data, tech denial, infrastructure, barcodes
-
Back in May of 2009, Johnson and Johnson purchased Los Angeles based Cougar Biotech who has been conducting the clinical trials for the prostate cancer drug for patients with cancer that has progressed to a serious state. Phase 3 of the studies is due to be released in Europe at a cancer meeting in Milan...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Sep 10 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Biotech, FDA, Congress, Prostate Cancer, drug manufacturers, Follow On Biotech, pipeline, cheap drugs, Cougar Biotech, Johnson and Johnson.m HIV
-
As technology rolls on and with the various areas of safety, devices and drugs we are living with today, the FDA might just in fact become the “most connected” federal agency as much of the work and research being done today that falls under the jurisdiction of the FDA depends on information gathered...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jul 27 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Medical Devices, FDA, Congress, cell phones, wireless, Telehealth, UCLA, FCC, participatory Sensing, devices that report data, tech denial, infrastructure
-
This is what it is, states can apply for grants to submit what type of business intelligence or mathematic functionality they plan to use to provide better figures based on configured algorithms to keep on top of economic conditions relative to health insurance premium adjustments. The entire...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jun 7 2010
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, health insurance, Health IT, Education, Congress, Business Intelligence, Algorithms, United HealthCare, Venture Capital, health reform, balance
-
I have written here about the various plans to market “genetic benefits” here with most of the recent announcements. Granted if a doctor believes a test should be done prior to writing a prescription, then we follow the advice of the doctor, but from what I have seen in recent articles here the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, May 19 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, personalized medicine, DNA, drugs, healthcare, Pharma, Congress, CVS, Patients, Walgreens, pharmacy benefit managers, High Frequency Healthcare, PBM
-
I made brief mention of what Medco was doing just a day ago and here’s additional information on their plan. Pharmacy Benefit Managers are now molding into a new area. Yesterday I focused on CVS and what they doing with their program. Medco has some specifics with selected drugs such...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, May 18 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, drugs, healthcare, Pharma, Congress, Pfizer, Johnson and Johnson, Patients, pharmacy benefit managers, High Frequency Healthcare, Gene Network Sciences, GNS, PBM
-
We talk about super computing on Wall Street and I mention occasionally how this technology slips over to healthcare and here’s one prime example. Obviously with risk management with health insurers, this would appear to be a company they would consider watching. Already major pharma companies...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Apr 27 2010
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, drugs, healthcare, Pharma, clinical trials, Congress, Pfizer, Johnson and Johnson, Investing, Wall Street, Patients, pharmacy benefit managers, High Frequency Healthcare, Gene Network Sciences, GNS, PBM
-
I am not picking on the FDA by any means, but there’s just a lot of work to be done after years of “infrastructure neglect”. When you read the link below they had to give out a grant to an insurance agency to help create and test their new safety program connected to the Sentinel Initiative...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Apr 5 2010
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Medical Devices, FDA, Congress, cell phones, wireless, UCLA, FCC, participatory Sensing, devices that report data, tech denial, infrastructure
-
Do you want safety or a lane to get a product to market rapidly? This is what the FDA is looking at. Not too long ago it was in the news that the NIH and others were looking to improve upon the “fast track” time to get products approved faster. You can’t have it both ways! It...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Mar 15 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Medical Devices, MRI, Security, FDA, Congress, Imaging, Sofware, radiation, healthcare reform, Conficker Virus, algorithims, tech denial, CT Scanner
-
As the world of the internet continues to grow it is starting to become more apparent that the reliance on the 3rd party negotiator is stating to fail. When you think about it, you can almost get all the information you want from the internet or hire a data mining professional to do it for you...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 15 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, My Commentaries, Congress, Internet, Politics, Lobbying, Transparency, healthcare reform, Drug Companies, tech denial, technically challenged, PhRMA
-
Last December Teva announced they were going to ask so now it looks like the FDA has given the ok to review. Due to lack of whatever you want to call it these days in Congress, there are no provisions where a generic version of a biotech drug (aka biosimilars) can be approved and the drug is viewed...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Feb 2 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Generic Drugs, Congress, Merck, Politics, Amgen, Intellectual property, Teva, Drug approvals, drugs discounts, biosimilar